2025 年年报点评：业绩符合预期，加速创新 转型，布局国际化出海 买入（维持） | [Table_EPS] 盈利预测与估值 | 2024A | 2025A | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 11,812 | 12,020 | 12,483 | 13,863 | 15,449 | | 同比（%） | (4.97) | 1.76 | 3.85 | 11.06 | 11.44 | | 归母净利润（百万元） | 2,061 | 2,023 | 2,055 | 2,338 | 2,777 | | 同比（%） | 5.50 | (1.84) | 1.59 | 13.73 | 18.80 | | EPS-最新摊薄（元/股） | 2.32 | 2.28 | 2.31 | 2.63 | 3.13 | | P/E（现价&最新摊薄） | 14.68 | 14.95 | 14.72 | 12.94 | 10.89 | 证券研究报告·公司点评报告·化学制药 丽珠集团（000513） | 收盘价(元) | 34. ...

Investment Rating - The report upgrades the investment rating of the company to "Buy" [10] Core Views - The IND application for BGM0504 has been accepted, marking a significant step for the company as it prepares to enter clinical trials with a rare dual-target oral peptide [9] - The potential of amylin is highlighted, with BGM1812 being a long-acting amylin analog currently in the preclinical stage, indicating a favorable competitive landscape [3] - The oral formulation of BGM0504 is expected to have better compliance and penetration compared to injectable forms, with the same molecular structure showing promising efficacy in previous studies [9] Financial Projections - The company forecasts total revenue of 1,180 million in 2023, increasing to 1,762 million by 2027, reflecting a compound annual growth rate (CAGR) of 18.21% [11] - The projected net profit attributable to the parent company is expected to rise from 202.47 million in 2023 to 433.39 million in 2027, with a notable growth rate of 43.06% in 2027 [11] - The earnings per share (EPS) is projected to increase from 0.48 in 2023 to 1.03 in 2027, indicating a strong upward trend in profitability [11] Market Data - The closing price of the stock is reported at 69.16 yuan, with a market capitalization of approximately 29,238.65 million [6] - The price-to-earnings (P/E) ratio is currently at 144.41, expected to decrease to 67.47 by 2027, suggesting improving valuation metrics as earnings grow [11]

Macro Strategy - The report analyzes the low consumption rate in China compared to 38 countries, indicating that while disposable income is relatively high, the consumption tendency is low, suggesting that the majority of residents have a willingness to consume but lack the ability to do so [1][11][12] - China's consumption rate is only 37.2%, which is 16.6 percentage points lower than the average of 53.8% among the 38 countries [11] - The report emphasizes the need to increase the income of the middle and low-income groups to stimulate consumption, as the current tax burden on these groups is low, which does not favor consumption [1][12] Fixed Income - Following the recent interest rate cuts, short-term interest rates have decreased while long-term rates have increased, indicating a market adjustment to the new monetary policy [5][17] - The report suggests that the long-term interest rate trend remains downward, but the market has overreacted to the rate cut expectations, requiring time for adjustment [5][17] - The current yield curve indicates a reasonable spread between 10-year and 1-year government bonds, suggesting potential investment opportunities in the bond market [5][17] Industry Insights - The report highlights the recent developments in BoRui Pharmaceutical, which is raising 500 million yuan through a private placement, with the controlling shareholder fully subscribing, indicating strong confidence in the company's pipeline [6] - The company is advancing its clinical trials for BGM0504, which shows promising results compared to its competitors, suggesting a potential competitive edge in the market [6] - The report also discusses Kangnong Agriculture's expansion in the Huanghuaihai region, projecting steady growth in profits for 2025 and 2026 due to increased sales [7][8] Communication Industry - Shengke Communication reported a revenue of 1.08 billion yuan in 2024, with a focus on high-end product development and cost optimization, leading to improved gross margins [9] - The company is increasing its R&D investment significantly, which is expected to drive future growth and align with the domestic demand for high-end networking products [9][10] - The report notes that the company has successfully entered the supply chains of major domestic network equipment manufacturers, indicating a strong market position [9]

请各位听众升级为见闻最新版APP，以便成功收听以下音频。 华见早安之声 市场概述 要闻 中美经贸中方牵头人、国务院副总理何立峰出席新闻发布会表示，中美达成重要共识，会谈取得实质性进展。 中国4月CPI同比降0.1%、与上月持平，PPI同比降幅扩大至2.7%。 日本首相石破茂重申"零关税"，要求美国全面取消汽车关税。 印巴双方宣布停火后不久，印控克什米尔地区再次传出爆炸声。印度指巴基斯坦违反停火协议，巴方否认。 乌克兰准备无条件停火至少30天，普京提议5月15日恢复俄乌谈判。泽连斯基：乌克兰已做好与俄罗斯举行会谈的准备。 野村：日本寿险美元资产占比过高，一旦减持或对冲，将对美元产生重大压力。 投资者关注贸易会谈进展、消化美联储政策及第一季度财报数据。 美股周五开盘上涨，三大指数大多小幅收跌，全周均下跌。特斯拉一度涨超7.8%，台积电盘初涨约3%后收窄至不足1%，Lyft因扭亏为盈且预订量增长，股 价飙升28%。中概指数全周累计跌1.4%。 10年期美债收益率周五波动不大，全周上涨约7个基点。美元指数一度跌超0.5%后企稳于100上方。黄金终结两连跌，美油盘中涨近2.6%。 中美经贸高层会谈取得了实质性进展，达成 ...